PMID- 35789592 OWN - NLM STAT- MEDLINE DCOM- 20220706 LR - 20220716 IS - 2314-6753 (Electronic) IS - 2314-6745 (Print) VI - 2022 DP - 2022 TI - Long-Term Metabolic Outcomes after Gestational Diabetes Mellitus (GDM): Results from the Odense GDM Follow-Up Study (OGFUS). PG - 4900209 LID - 10.1155/2022/4900209 [doi] LID - 4900209 AB - AIMS: To compare metabolic profiles and the long-term risk of metabolic dysfunction between women with previous gestational diabetes mellitus (pGDM) and women without pGDM (non-GDM) matched on age, prepregnancy body mass index (BMI), and parity. METHODS: In total, 128 women with pGDM (median follow-up: 7.8 years) and 70 non-GDM controls (median follow-up: 10.0 years) completed a 2 h oral glucose tolerance test (OGTT) with assessment of glucose, C-peptide, insulin, and other metabolic measures. Additionally, anthropometrics, fat mass, and blood pressure were assessed and indices of insulin sensitivity and beta cell function were calculated. RESULTS: The prevalence of type 2 diabetes mellitus (T2DM) was significantly higher in the pGDM group compared to the non-GDM group (26% vs. 0%). For women with pGDM, the prevalence of prediabetes (38%) and the metabolic syndrome (MetS) (59%) were approximately 3-fold higher than in non-GDM women (p's < 0.001). Both insulin sensitivity and beta cell function were significantly reduced in pGDM women compared to non-GDM women. CONCLUSION: Despite similar BMI, women with pGDM had a substantially higher risk of developing T2DM, prediabetes, and the MetS compared to controls. Both beta cell dysfunction and reduced insulin sensitivity seem to contribute to this increased risk. CI - Copyright (c) 2022 Kristine Hovde Jacobsen et al. FAU - Jacobsen, Kristine Hovde AU - Jacobsen KH AUID- ORCID: 0000-0002-3808-011X AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. FAU - Aalders, Jori AU - Aalders J AUID- ORCID: 0000-0002-7207-8304 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. AD - Department of Clinical Research, University of Southern Denmark, Odense, Denmark. AD - Department of Psychology, University of Southern Denmark, Odense, Denmark. FAU - Solling, Katrine AU - Solling K AUID- ORCID: 0000-0002-3695-7344 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. FAU - Andersen, Marianne Skovsager AU - Andersen MS AUID- ORCID: 0000-0002-4603-9504 AD - Department of Clinical Research, University of Southern Denmark, Odense, Denmark. AD - Department of Endocrinology, Odense University Hospital, Odense, Denmark. FAU - Snogdal, Lena Sonder AU - Snogdal LS AUID- ORCID: 0000-0001-8999-4651 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. FAU - Christensen, Maria Hornstrup AU - Christensen MH AUID- ORCID: 0000-0002-4985-4491 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. AD - Department of Clinical Research, University of Southern Denmark, Odense, Denmark. AD - Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark. FAU - Vinter, Christina Anne AU - Vinter CA AUID- ORCID: 0000-0001-5084-6053 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. AD - Department of Endocrinology, Odense University Hospital, Odense, Denmark. AD - Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark. FAU - Hojlund, Kurt AU - Hojlund K AUID- ORCID: 0000-0002-0891-4224 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. AD - Department of Endocrinology, Odense University Hospital, Odense, Denmark. FAU - Jensen, Dorte Moller AU - Jensen DM AUID- ORCID: 0000-0002-3298-9824 AD - Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. AD - Department of Endocrinology, Odense University Hospital, Odense, Denmark. AD - Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark. LA - eng PT - Journal Article DEP - 20220625 PL - England TA - J Diabetes Res JT - Journal of diabetes research JID - 101605237 RN - 0 (Insulin) SB - IM MH - *Diabetes Mellitus, Type 2/epidemiology MH - *Diabetes, Gestational MH - Female MH - Follow-Up Studies MH - Humans MH - Insulin/therapeutic use MH - *Insulin Resistance MH - *Metabolic Syndrome/epidemiology MH - *Prediabetic State/epidemiology MH - Pregnancy PMC - PMC9250439 COIS- The authors declare that there is no conflict of interest regarding the publication of this article. EDAT- 2022/07/06 06:00 MHDA- 2022/07/07 06:00 PMCR- 2022/06/25 CRDT- 2022/07/05 19:47 PHST- 2021/12/23 00:00 [received] PHST- 2022/03/28 00:00 [revised] PHST- 2022/05/10 00:00 [accepted] PHST- 2022/07/05 19:47 [entrez] PHST- 2022/07/06 06:00 [pubmed] PHST- 2022/07/07 06:00 [medline] PHST- 2022/06/25 00:00 [pmc-release] AID - 10.1155/2022/4900209 [doi] PST - epublish SO - J Diabetes Res. 2022 Jun 25;2022:4900209. doi: 10.1155/2022/4900209. eCollection 2022.